Enjoy complimentary customisation on priority with our Enterprise License!
The pharmaceutical glass packaging market is estimated to grow at a CAGR of 6% between 2022 and 2027. The size of the market is forecast to increase by USD 5,742.88 million. The growth of the market depends on several factors, including an increase in R&D spending in the pharmaceutical industry, growing sales of pharmaceuticals, and the growing use of cryogenic vials in drug research and development.
This report extensively covers market segmentation by type (generic, branded, and biologic), product (bottles, ampoules and vials, syringes, and cartridges), and geography (North America, APAC, Europe, South America, and Middle East and Africa). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The increase in R&D spending in the pharmaceutical industry is notably driving the market growth, although factors such as the risk of counterfeiting in pharmaceutical glass packaging may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increase in R&D spending in the pharmaceutical industry is notably driving the market growth. Many pharmaceutical companies are making significant R&D investments. A pharmaceutical company typically invests between 15% and 20% of its revenue in research and development. The number of pharmaceutical products on the market is anticipated to rise, driving demand for pharmaceutical glass packaging as a result of increased R&D spending by pharmaceutical manufacturers.
Pharmaceutical manufacturers can lower their capital expenditure and associated operating costs with regard to the purchase of glass packaging machinery, space for setting up a glass packaging unit, and labor costs by outsourcing glass packaging operations to third-party vendors. Pharmaceutical manufacturers also focus on their core competencies by contracting with outside providers of packaging services. Therefore, the rising R&D spending by pharmaceutical manufacturers and increasing production of pharmaceutical products such as biologics, vials, and others are expected to increase the demand for pharmaceutical glass packaging during the forecast period.
The expansion of manufacturing facilities is an emerging trend in the market. Pharmaceutical glass packaging vendors are expanding their manufacturing facilities to keep up with the demand for pharmaceutical products like medicines, vaccines, and other goods.
One of the instances of expansion by the vendors includes the announcement made by Schott AG in November 2021 in its new pharma glass tubing factory in Jinyun, China, to meet the growing demand for high-quality glass tubing for primary pharmaceutical packaging. Similarly, Piramida, a Croatian manufacturer of glass pharmaceutical packaging, was purchased by Nipro Corp. in May 2021. The acquisition will enable Piramida to strengthen its position in Europe and other international markets while enabling Nipro to meet the rising demand for pharmaceutical glass packaging in the Central European market. Thus, the growing expansion of manufacturing facilities by the vendors will drive the market during the forecast period.
The risk of counterfeiting in pharmaceutical glass packaging is a major challenge impeding market growth. The lives of consumers may be in danger from counterfeit drugs. Vendors of glass and pharmaceutical packaging may also suffer financially as a result. Additionally, the consequences of using fake medications can harm a company's reputation. There are numerous intermediaries in the complex global pharmaceutical supply chain. Consequently, there is a chance that the genuine item will be taken or changed for a replica. Before the drugs reach the final consumer, the original drugs may be replaced or stolen at either the beginning or the end of the supply chain.
Pharmaceutical glass packaging vendors are increasingly investing and adopting anti-counterfeit techniques in packaging, such as security printing (comprises micro text, watermark, and latent image), track and trace (such as barcodes and serialization), covert identifiers and trace (includes micro taggants and micro-mapping), and holography (holograms, embedded barcodes, logos, and hidden messages). However, this will increase the cost of production, which in turn will decrease the vendor's profit margins. Therefore, such factors will hinder the market growth during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Pharmaceutical Glass Packaging Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Arab Pharmaceutical Glass Co. - The company is a private organization whose business operations are in the pharmaceuticals, biotechnology, and life sciences sectors. The key offerings of the company include pharmaceutical glass packagings solutions such as vials, jars, and bottles.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the generic segment will be significant during the forecast period. Glass has many advantages as a packaging material, including sustainability, inertness, impermeability, recyclability without losing quality, and reusability. It is the perfect material for securely storing and shielding products. Glass packaging is therefore used for a variety of generic drugs due to its advantages.
Get a glance at the market contribution of various segments Request a PDF Sample
The generic segment was valued at USD 9,235.51 in 2017 and continued to grow until 2021. Since generic drug applicants do not need to repeat the animal and clinical (human studies) studies that were necessary to prove the safety and efficacy of name-brand medications, generic medications are more affordable than branded ones. Due to lower initial drug development costs, generic drug companies are able to offer their products at prices that are about 85% lower than those of their brand-name counterparts. Generic medications also contain identical active ingredients that are comparable to the branded medication's strength, stability, purity, efficacy, and safety. The acceptance of generic medications due to their low cost has also made it possible for developing nations to access these medications for the treatment of various diseases. Therefore, the low cost of generics, their growing use in emerging markets, and their effectiveness lead people to opt for generic drugs, thereby contributing to the growth of the market during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
APAC is estimated to contribute 34% to the growth of the global market during the forecast period. Another region offering significant growth opportunities to vendors is North America. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The region's demand for pharmaceutical glass packaging is anticipated to increase significantly due to the growing elderly population in North America. By 2035, there will be more than 78 million elderly people (those over 65), according to the US Census Bureau. The demand for value-added goods is fueled by regulatory standards that promote senior-friendly pharmaceutical packaging options with extra security features like child-resistant closures. During the forecast period, it is also anticipated that increasing tin and steel plating for the production of caps and a shift in consumer preference toward plastic substitutes like glass in beverage packaging will aid in the market's expansion.
The US is the major contributor to the market in North America. The growing value of the US pharmaceutical exports, increasing healthcare spending, and the rising aging population are the major factors driving the market. The expansion of government healthcare insurance programs also fuels the market. The US system of intellectual property is driving up the market price of patented medicines. As a result, the US pharmaceutical industry is drawing a lot of venture capital investment. The rising healthcare spending in the US is also anticipated to increase demand for pharmaceutical glass packaging in the nation over the course of the forecast period.
The outbreak of COVID-19 impacted the market in a positive manner in the region. Patients required high-quality medical facilities and medicines for their treatment. This boosted the demand for drugs, which in turn, boosted the market growth in the region. Hence, the growth of the pharmaceutical glass packaging market in North America increased in 2020. Furthermore, the initiation of vaccination drives in the first half of 2021 has led to a rise in production activities in end-user industries, which generated the demand for pharmaceutical glass packaging solutions. Such factors are expected to drive the growth of the pharmaceutical glass packaging market during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Technavio categorizes the global pharmaceutical glass packaging market as a part of the global metal and glass containers market within the overall global containers and packaging market. The global metal and glass containers market includes products of metal, glass, or plastic containers, including corks and caps. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
Pharmaceutical Glass Packaging Market Scope |
|
Report Coverage |
Details |
Page number |
173 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
Market growth 2023-2027 |
USD 5,742.88 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
5.6 |
Regional analysis |
North America, APAC, Europe, South America, and Middle East and Africa |
Performing market contribution |
APAC at 34% |
Key countries |
US, China, India, Russia, and UK |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Acme Vial and Glass Co. LLC, Arab Pharmaceutical Glass Co., Ardagh Group SA, Beatson Clark, Becton Dickinson and Co., Bormioli Pharma Spa, Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Hindustan National Glass and Industries Ltd., Nipro Corp., O I Glass Inc., PGP Glass Pvt. Ltd., SCHOTT AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Sisecam, Stevanato Group S.p.A, West Pharmaceutical Services Inc., and Stoelzle Oberglas GmbH |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.